Drug intelligence / Profile preview

miR-148a-5p inhibitor

Development stage
Preclinical
Modality
Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Modified DNA Oligonucleotides → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Single-strand DNA → Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Subcutaneous, Intrathecal, Intravitreal, Inhalation, Intranasal, Parenteral, Implant
01

Overview

miR-148a-5p inhibitor is a synthetic antisense oligonucleotide designed to bind and neutralize the activity of microRNA-148a-5p. In the context of multiple myeloma (MM) research, miR-148a-5p has been identified as being significantly overexpressed in patients compared to healthy controls. While its sister strand, miR-148a-3p, has been shown to promote cell proliferation and target tumor suppressors like CCDC6, experimental inhibition of miR-148a-5p specifically has not demonstrated significant alterations in cell proliferation in certain MM cell lines (e.g., KMS28BM, KMS27). These inhibitors are primarily used as research tools to investigate the functional role of specific miRNA strands in oncogenesis and gene regulation, though they represent a potential class of RNA-targeted therapeutics.

Other names
microRNA-148a-5p inhibitormicroRNA148a-5p inhibitormicroRNA 148a-5p inhibitoranti-miR-148a-5panti-miR148a-5panti-miR 148a-5pantagomir-148a-5pantagomir148a-5pantagomir 148a-5p
02

Targets

miR-148a-5p (MicroRNA 148a-5p)

Beyond the preview

Go deeper on miR-148a-5p inhibitor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-148a-5p inhibitor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call